Effect of Histone Deacetylase Inhibitors on HIV Production in Latently Infected, Resting CD4+ T Cells From Infected Individuals Receiving Effective Antiretroviral Therapy

被引:81
作者
Blazkova, Jana
Chun, Tae-Wook [1 ]
Belay, Bietel W.
Murray, Danielle
Justement, J. Shawn
Funk, Emily K.
Nelson, Amy
Hallahan, Claire W.
Moir, Susan
Wender, Paul A. [2 ]
Fauci, Anthony S.
机构
[1] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA
[2] Stanford Univ, Dept Chem, Stanford, CA 94305 USA
基金
美国国家卫生研究院;
关键词
VALPROIC ACID; RESERVOIR; PROSTRATIN; EXPRESSION; AIDS;
D O I
10.1093/infdis/jis412
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Persistence of the latent viral reservoir has been recognized as a major obstacle to eradicating human immunodeficiency virus (HIV) in infected individuals receiving antiretroviral therapy. It has been suggested that histone deacetylase inhibitors (HDACis) may purge HIV in the latent viral reservoir. However, the effect of HDACis on the degree and extent of HIV expression in the latent viral reservoir has not been fully delineated. Here we demonstrate that HDACis do not induce HIV production in the latent viral reservoir of aviremic individuals. Therefore, alternative therapeutic strategies may be necessary to eliminate HIV in the latent viral reservoir.
引用
收藏
页码:765 / 769
页数:5
相关论文
共 15 条
  • [1] Expression of Latent HIV Induced by the Potent HDAC Inhibitor Suberoylanilide Hydroxamic Acid
    Archin, Nancie M.
    Espeseth, Amy
    Parker, Daniel
    Cheema, Manzoor
    Hazuda, Daria
    Margolis, David M.
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2009, 25 (02) : 207 - 212
  • [2] HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir
    Chun, TW
    Nickle, DC
    Justement, JS
    Large, D
    Semerjian, A
    Curlin, ME
    O'Shea, MA
    Hallahan, CW
    Daucher, M
    Ward, DJ
    Moir, S
    Mullins, JI
    Kovacs, C
    Fauci, AS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (11) : 3250 - 3255
  • [3] AIDS - Re-emergence of HIV after stopping therapy
    Chun, TW
    Davey, RT
    Engel, D
    Lane, HC
    Fauci, AS
    [J]. NATURE, 1999, 401 (6756) : 874 - 875
  • [4] Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy
    Chun, TW
    Engel, D
    Mizell, SB
    Hallahan, CW
    Fischette, M
    Park, S
    Davey, RT
    Dybul, M
    Kovacs, JA
    Metcalf, JA
    Mican, JM
    Berrey, MM
    Corey, L
    Lane, HC
    Fauci, AS
    [J]. NATURE MEDICINE, 1999, 5 (06) : 651 - 655
  • [5] GENETIC-RELATIONSHIPS DETERMINED BY A DNA HETERODUPLEX MOBILITY ASSAY - ANALYSIS OF HIV-1 ENV GENES
    DELWART, EL
    SHPAER, EG
    LOUWAGIE, J
    MCCUTCHAN, FE
    GREZ, M
    RUBSAMENWAIGMANN, H
    MULLINS, JI
    [J]. SCIENCE, 1993, 262 (5137) : 1257 - 1261
  • [6] Inhibitors of Histone Deacetylases CORRELATION BETWEEN ISOFORM SPECIFICITY AND REACTIVATION OF HIV TYPE 1 (HIV- 1) FROM LATENTLY INFECTED CELLS
    Huber, Kelly
    Doyon, Genevieve
    Plaks, Joseph
    Fyne, Elizabeth
    Mellors, John W.
    Sluis-Cremer, Nicolas
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (25) : 22211 - 22218
  • [7] Intensification and stimulation therapy for human immunodeficiency virus type 1 reservoirs in infected persons receiving virally suppressive highly active antiretroviral therapy
    Kulkosky, J
    Nunnari, G
    Otero, M
    Calarota, S
    Dornadula, G
    Zhang, H
    Malin, A
    Sullivan, J
    Xu, Y
    DeSimone, J
    Babinchak, T
    Stern, J
    Cavert, W
    Haase, A
    Pomerantz, RJ
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (10) : 1403 - 1411
  • [8] Depletion of latent HIV-1 infection in vivo: a proof-of-concept study
    Lehrman, G
    Hogue, IB
    Palmer, S
    Jennings, C
    Spina, CA
    Wiegand, A
    Landay, AL
    Coombs, RW
    Richman, DD
    Mellors, JW
    Coffin, JM
    Bosch, RJ
    Margolis, DM
    [J]. LANCET, 2005, 366 (9485) : 549 - 555
  • [9] Histone deacetylase inhibitors and HIV latency
    Margolis, David M.
    [J]. CURRENT OPINION IN HIV AND AIDS, 2011, 6 (01) : 25 - 29
  • [10] Synergistic Activation of HIV-1 Expression by Deacetylase Inhibitors and Prostratin: Implications for Treatment of Latent Infection
    Reuse, Sophie
    Calao, Miriam
    Kabeya, Kabamba
    Guiguen, Allan
    Gatot, Jean-Stephane
    Quivy, Vincent
    Vanhulle, Caroline
    Lamine, Aurelia
    Vaira, Dolores
    Demonte, Dominique
    Martinelli, Valerie
    Veithen, Emmanuelle
    Cherrier, Thomas
    Avettand, Veronique
    Poutrel, Solene
    Piette, Jacques
    de Launoit, Yvan
    Moutschen, Michel
    Burny, Arsene
    Rouzioux, Christine
    De Wit, Stephane
    Herbein, Georges
    Rohr, Olivier
    Collette, Yves
    Lambotte, Olivier
    Clumeck, Nathan
    Van Lint, Carine
    [J]. PLOS ONE, 2009, 4 (06):